- Mefruside
-
Mefruside Systematic (IUPAC) name 4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ℞ Prescription only Routes Oral Identifiers CAS number 7195-27-9 ATC code C03BA05 PubChem CID 4047 UNII X1NS9SNS92 KEGG D01877 Chemical data Formula C13H19ClN2O5S2 Mol. mass 382.88 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]
It was developed by Bayer A.G. and is sold under the tradename Baycaron.
References
- ^ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.
Antihypertensives: diuretics (C03) Sulfonamides
(except EA)CA inhibitors (at PT)Thiazide-likes (primarily DCT)Quinethazone • Clopamide • Chlortalidone • Mefruside • Clofenamide • Metolazone • Meticrane • Xipamide • Indapamide • Clorexolone • FenquizonePotassium-sparing (at CD) ESC blockersOsmotic diuretics (PT, DL) VAs (DCT and CD) vaptans: Conivaptan • Mozavaptan • Satavaptan • Tolvaptan
tetracyclines: DemeclocyclineOther #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.